The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
Open accessAbstract
Background Sudden unexplained death in psychiatric patients may be due to drug-induced arrhythmia, of which lengthening of the rate-corrected QT interval (QTc) on the electrocardiogram is a predictive marker. We estimated the point prevalence of QTc lengthening in psychiatric patients and the effects of various psychotropic drugs.Methods Electrocardiograms were obtained from 101 healthy reference individuals and 495 psychiatric patients in various inpatient and community settings and were analysed with a previously validated digitiser technique. Patients with and without QTc lengthening, QTc dispersion, and T-wave abnormality were compared by logistic regression to calculate odds ratios for predictive variables.Findings Abnormal QTc was defined from the healthy reference group as more than 456 ms and was present in 8% (40 of 495) of patients. Age over 65 years (odds ratio 3.0 [95% CI 1.1-8.3]), use of tricyclic antidepressants (4.4 [1.6-12.1]), thioridazine (5.4 [2.0-13.7]), and droperidol (6.7 [1.8-24.8]) were robust predictors of QTc lengthening, as was antipsychotic dose (high dose 5.3 [1.2-24.4]; very high dose 8.2 [1.5-43.6]). Abnormal QT dispersion or T-wave abnormalities were not significantly associated with antipsychotic treatment, but were associated with lithium therapy.Interpretation Antipsychotic drugs cause QTc lengthening in a dose-related manner. Risks are substantially higher for thioridazine and droperidol. These drugs may therefore confer an increased risk of drug-induced arrhythmia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lithium can increase the risk of abnormal QT prolongation or T‐wave abnormalities,834 an impact more pronounced with age, as almost 60% of older patients on lithium maintenance therapy have ECG abnormalities.835”
In the citing paper
“Adverse events associated with typical antipsychotics include all of those associated with atypical agents (below) as well as a greater risk of anticholinergic effects, hyperprolactinemia, postural hypotension, prolonged QT, sexual dysfunction, and extrapyramidal symptoms (including parkinsonism, dystonia, and tardive dyskinesia).108 113 114”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [114]
Citations
Cites
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.
Day, C. P., McComb, J. M., & Campbell, R. W. (1990) · Heart · doi:10.1136/hrt.63.6.342 · Cited by 1,189
QT dispersion and sudden unexpected death in chronic heart failure
Barr, C. S., Naas, A., Freeman, M., Lang, C. C., & Struthers, A. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91164-9 · Cited by 769
Algra, A., Tijssen, J. G., Roelandt, J. R., Pool, J., & Lubsen, J. (1991) · Circulation · doi:10.1161/01.cir.83.6.1888 · Cited by 592
Hii, J. T., Wyse, D. G., Gillis, A. M., Duff, H. J., Solylo, M. A., & Mitchell, L. B. (1992) · Circulation · doi:10.1161/01.cir.86.5.1376 · Cited by 385
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 371
Short‐and Long‐Term Reproducibility of QT, QTc, and QT Dispersion Measurement in Healthy Subjects
KAUTZNER, J., YI, G., CAMM, A. J., & MALIK, M. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb01435.x · Cited by 250
REY, M.-J., SCHULZ, P., COSTA, C., DICK, P., & TISSOT, R. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198904000-00001 · Cited by 190
Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications
Atkins, M., Burgess, A., Bottomley, C., & Riccio, M. (1997) · Psychiatric Bulletin · doi:10.1192/pb.21.4.224 · Cited by 170
Giardina, E. G., Bigger, J. T., Glassman, A. H., Perel, J. M., & Kantor, S. J. (1979) · Circulation · doi:10.1161/01.cir.60.5.1045 · Cited by 167
The Use of High-Dose Antipsychotic Medication
Thompson, C. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.4.448 · Cited by 152
Research works printed but not linked: 2
- Hartigan-Go, 1995, Inter and intraobserver errors in the measurement of the QT interval and QT dispersion, Br J Clin Pharmacol, 39, 104P
- Kirchner, 1998, A systematic review of the evidence for the safety and efficacy of thioridazine in dementia
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Assessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S., Fang, B., Peterson, E., Aquino, P. R., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 907
Metadata
- Authors
- Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S.
- Affiliations
- South Tees Hospitals NHS Foundation Trust (GB)
- Newcastle University (GB)
- Corresponding author
- Thomas, SHL
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 355
- Issue
- 9209
- Pages
- 1048-1052
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2095984135
- Cited by
- 602
- References
- 24
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 7 · 2023: 9 · 2022: 12 · 2021: 15 · 2020: 11 · 2019: 13 · 2018: 7 · 2017: 20 · 2016: 24 · 2015: 27 · 2014: 26 · 2013: 17 · 2012: 22
- FWCI
- 34.36
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- QTc prolongation, drug-induced arrhythmia, psychotropic drugs, antipsychotic drugs, tricyclic antidepressants, thioridazine, droperidol, lithium, QT dispersion, T wave changes, sudden cardiac death, psychiatric patients, antipsychotic dosing
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Cause of Death, Dose-Response Relationship, Drug, Electrocardiography, England, Female, Humans, Long QT Syndrome, Male, Middle Aged, Psychotropic Drugs, Risk Factors, Antipsychotic Agents, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. https://app.cochat.ai/papers/10.1016/s0140-6736(00)02035-3
- The paper
- Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S. (2000). QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. The Lancet. https://doi.org/10.1016/s0140-6736(00)02035-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.